329
Views
7
CrossRef citations to date
0
Altmetric
Reviews

West Nile virus infection in children

, , , , &

References

  • Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA 2013;310:308-15
  • Rizzoli A, Jimenez-Clavero MA, Barzon L, et al. The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill 2015;20
  • Chung WM, Buseman CM, Joyner SN, et al. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 2013;310:297-307
  • Smith JC, Mailman T, MacDonald NE. West Nile virus: should pediatricians care? J Infect 2014;69(Suppl 1):S70-6
  • Wilson CA, Bale JFJr. West Nile virus infections in children. Curr Infect Dis Rep 2014;16:931
  • Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940;20:471-2
  • Kilpatrick AM, Daszak P, Jones MJ, et al. Host heterogeneity dominates West Nile virus transmission. Proc Biol Sci 2006;273:2327-33
  • Rizzoli A, Bolzoni L, Chadwick EA, et al. Understanding West Nile virus ecology in Europe: Culex pipiens host feeding preference in a hotspot of virus emergence. Parasit Vectors 2015;8:213
  • Engler O, Savini G, Papa A, et al. European surveillance for West Nile virus in mosquito populations. Int J Environ Res Public Health 2013;10:4869-95
  • Kilpatrick AM, Meola MA, Moudy RM, Kramer LD. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 2008;4:e1000092
  • Hartley DM, Barker CM, Le Menach A, et al. Effects of temperature on emergence and seasonality of West Nile virus in California. Am J Trop Med Hyg 2012;86:884-94
  • Reisen WK. Ecology of West Nile virus in North America. Viruses 2013;5:2079-105
  • Kwan JL, Kluh S, Reisen WK. Antecedent avian immunity limits tangential transmission of West Nile virus to humans. PLoS One 2012;7:e34127
  • Montgomery RR, Murray KO. Risk factors for West Nile virus infection and diseases in populations and individuals. Expert Rev Anti Infect Ther 2015;13:317-25
  • Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45
  • Basavaraju SV, Kuehnert MJ, Zaki SR, Sejvar JJ. Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013. Emerg Infect Dis 2014;20:1443-51
  • Montgomery SP, Brown JA, Kuehnert M, et al. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. Transfusion 2006;46:2038-46
  • Centers for Disease Control and Prevention (CDC). West Nile virus transmission through blood transfusion – South Dakota, 2006. MMWR Morb Mortal Wkky Rep 2007;56:76-9
  • O’Leary DR, Kuhn S, Kniss KL, et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006;117:e537-45
  • Hayes EB, O’Leary DR. West Nile virus infection: a pediatric perspective. Pediatrics 2004;113:1375-81
  • Centers for Disease Control and Prevention (CDC). Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002;51:877-8
  • Hinckley AF, O’Leary DR, Hayes EB. Transmission of West Nile virus through human breast milk seems to be rare. Pediatrics 2007;119:e666-71
  • Lindsey NP, Hayes EB, Staples JE, Fischer M. West Nile virus disease in children, United States, 1999-2007. Pediatrics 2009;123:e1084-9
  • Centers for Disease Control and Prevention (CDC). Intrauterine West Nile virus infection-New York. 2002. MMWR Morb Mortal Wkly Rep 2002;51:1135-6
  • Alpert SG, Fergerson J, Noël LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 2003;136:733-5
  • Chapa JB, Ahn JT, DiGiovanni LM, Ismail MA. West Nile virus encephalitis during pregnancy. Obstet Gynecol 2003;102:229-31
  • Sirois PA, Pridjian G, McRae S, et al. Developmental outcomes in young children born to mothers with West Nile illness during pregnancy. Birth Defects Res A Clin Mol Teratol 2014;100:792-6
  • Paisley JE, Hinckley AF, O’Leary DR, et al. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics 2006;117:814-20
  • Centers for Disease Control and Prevention (CDC). Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb Mortal Wkly Rep 2004;53:154
  • Available from: www.cdc.gov/breastfeeding/disease/west_nile_virus.htm
  • Available from: www.cdc.gov/westnile/faq/pregnancy.html
  • Civen R, Villacorte F, Robles DT, et al. West Nile virus infection in the pediatric population. Pediatr Infect Dis J 2006;25:75-8
  • Weber IB, Lindsey NP, Bunko-Patterson AM, et al. Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona. USA. Epidemiol Infect 2012;140:1632-6
  • Barzon L, Squarzon L, Cattai M, et al. West Nile virus infection in Veneto region, Italy, 2008-2009. Euro Surveill 2009;14
  • Rizzo C, Vescio F, Declich S, et al. West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill 2009;14
  • Sirbu A, Ceianu CS, Panculescu-Gatej RI, et al. Outbreak of West Nile virus infection in humans, Romania, July to October 2010. Euro Surveill 2011;16
  • Gaensbauer JT, Lindsey NP, Messacar K, et al. Neuroinvasive arboviral disease in the United States: 2003 to 2012. Pediatrics 2014;134:e642-50
  • Murray KO, Ruktanonchai D, Hesalroad D, et al. West Nile virus, Texas, USA, 2012. Emerg Infect Dis 2013;19:1836-8
  • Nolan MS, Schuermann J, Murray KO. West Nile virus infection among humans, Texas, USA, 2002-2011. Emerg Infect Dis 2013;19:137-9
  • Tsai TF, Popovici F, Cernescu C, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998;352:767-71
  • Danis K, Papa A, Theocharopoulos G, et al. Outbreak of West Nile virus infection in Greece, 2010. Emerg Infect Dis 2011;17:1868-72
  • Papa A. West Nile infections in humans – focus on Greece. J Clin Cirol 2013;58:351-3
  • Pervanidou D, Detsis M, Danis K, et al. West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmission. Euro Surveill 2014;19:13
  • Rizzo C, Salcuni P, Nicoletti L, et al. Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011. Euro Surveill 2012;17
  • Barzon L, Pacenti M, Cusinato R, et al. Human cases of West Nile Virus infection in north-eastern Italy, 15 June to 15 November 2010. Euro Surveill 2011;16
  • Barzon L, Pacenti M, Franchin E, et al. Novel West Nile virus lineage 1a full genome sequences from human cases of infection in north-eastern Italy, 2011. Clin Microbiol Infect 2012;18:E541-4
  • Gobbi F, Capelli G, Angheben A, et al. Human and entomological surveillance of West Nile fever, dengue and chikungunya in Veneto Region, Italy, 2010-2012. BMC Infect Dis 2014;14:60
  • Barzon L, Pacenti M, Franchin E, et al. Large human outbreak of West Nile virus infection in north-eastern Italy in. 2012. Viruses 2013;5:2825-39
  • Barzon L, Pacenti M, Franchin E, et al. Whole genome sequencing and phylogenetic analysis of West Nile virus lineage 1 and lineage 2 from human cases of infection, Italy, August 2013. Euro Surveill 2013;18
  • Barzon L, Papa A, Lavezzo E, et al. Phylogenetic characterization of Central-Southern European lineage 2 West Nile virus: Analysis of human outbreaks in Italy and Greece, 2013-2014. Clin Microbiol Infect 2015. doi:10.1016/j.cmi.2015.07.018
  • Kalaycioglu H, Korukluoglu G, Ozkul A, et al. Emergence of West Nile virus infections in humans in Turkey, 2010 to 2011. Euro Surveill 2012;17
  • Weinberger M, Pitlik SD, Gandacu D, et al. West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis 2001;7:686-91
  • Kopel E, Amitai Z, Bin H, et al. Surveillance of West Nile virus disease, Tel Aviv district, Israel, 2005 to 2010. Euro Surveill 2011;16
  • Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 2001;7:128-32
  • Lvov DK, Butenko AM, Gromashevsky VL, et al. Isolation of two strains of West Nile virus during an outbreak in southern Russia, 1999. Emerg Infect Dis 2000;6:373-6
  • Anukumar B, Sapkal GN, Tandale BV, et al. West Nile encephalitis outbreak in Kerala, India, 2011. J Clin Virol 2014;61:152-5
  • LaBeaud AD, Kile JR, Kippes C, et al. Exposure to West Nile virus during the 2002 epidemic in Cuyahoga County, Ohio: a comparison of pediatric and adult behaviors. Public Health Rep 2007;122:356-61
  • LaBeaud AD, Glinka A, Kippes C, King CH. School-based health promotion for mosquito-borne disease prevention in children. J Pediatr 2009;155:590-2
  • Suthar MS, Diamond MS, Gale MJr. West Nile virus infection and immunity. Nat Rev Microbiol 2013;11(2):115-28
  • Sejvar JJ. Clinical manifestations and outcomes of West Nile virus infection. Viruses 2014;6:606-23
  • Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001;7:675-8
  • Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007;44:1617-24
  • Smith RD, Konoplev S, DeCourten-Myers G, Brown T. West Nile virus encephalitis with myositis and orchitis. Hum Pathol 2004;35:254-8
  • Quatresous I, Salomon B, Noel D. Orchitis and West Nile encephalitis. Med Mal Infect 2013;43:481-2
  • Kramer LD, Li J, Shi PY. West Nile virus. Lancet Neurol 2007;6:171-81
  • Koevary SB. Ocular involvement in patients infected by the West Nile virus. Optometry 2005;76:609-12
  • Murray KO, Garcia MN, Rahbar MH, et al. Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort. PLoS ONE 2014;9:e102953
  • Weatherhead JE, Miller VE, Garcia MN, et al. Long-term neurological outcomes in West Nile virus-infected patients: an observational study. Am J Trop Med Hyg 2015;92:1006-12
  • Patel H, Sander B, Nelder MP. Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect Dis 2015;S1473-3099(15):00134-6
  • Anastasiadou A, Kakoulidis I, Butel D, et al. Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis 2013;17:e494-7
  • Sejvar JJ, Lindsey NP, Campbell GL. Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. Vector Borne Zoonotic Dis 2011;11:161-4
  • Carson PJ, Borchardt SM, Custer B, et al. Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis 2012;18:684-6
  • Popović N, Milošević B, Urošević A, et al. Outbreak of West Nile virus infection among humans in Serbia, August to October 2012. Euro Surveill 2013;18
  • Lindsey NP, Staples JE, Lehman JA, Fischer M. Medical risk factors for severe West Nile Virus disease, United States, 2008-2010. Am J Trop Med Hyg 2012;87:179-84
  • Murray K, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 2006;134:1325-32
  • Freifeld AG, Meza J, Schweitzer B, et al. Seroprevalence of West Nile virus infection in solid organ transplant recipients. Transpl Infect Dis 2010;12:120-6
  • Donadieu E, Bahuon C, Lowenski S, et al. Differential virulence and pathogenesis of West Nile viruses. Viruses 2013;5:2856-80
  • Lim SM, Brault AC, van Amerongen G, et al. Susceptibility of carrion crows to experimental infection with lineage 1 and 2 West Nile viruses. Emerg Infect Dis 2015;21:1357-65
  • Lim SM, Brault AC, van Amerongen G, et al. Susceptibility of European jackdaws (Corvus monedula) to experimental infection with lineage 1 and 2 West Nile viruses. J Gen Virol 2014;95:1320-9
  • Ziegler U, Angenvoort J, Fischer D, et al. Pathogenesis of West Nile virus lineage 1 and 2 in experimentally infected large falcons. Vet Microbiol 2013;161:263-73
  • Francisco AM, Glaser C, Frykman E, et al. 2004;California pediatric West Nile virus case series. Pediatr Infect Dis J 2006 25:81-4
  • Ferguson DD, Gershman K, LeBailly A, Petersen LR. Characteristics of the rash associated with West Nile virus fever. Clin Infect Dis 2005;41:1204-7
  • LaBeaud AD, Lisgaris MV, King CH, Mandalakas AM. Pediatric West Nile virus infection: neurologic disease presentations during the 2002 epidemic in Cuyahoga County, Ohio. Pediatr Infect Dis J 2006;25:751-3
  • Soldatou A, Vartzelis G, Vorre S, et al. A toddler with acute flaccid paralysis due to West Nile virus infection. Pediatr Infect Dis J 2013;32:1023-4
  • Moon TD, Nadimpalli A, Martin EB, et al. Balance and gait abnormalities of a child with West Nile virus infection. Pediatr Infect Dis J 2005;24:568-70
  • Arnold JC, Revivo GA, Senac MO, Leake JA. West Nile virus encephalitis with thalamic involvement in an immunocompromised child. Pediatr Infect Dis J 2005;24:932-4
  • Hainline ML, Kincaid JC, Carpenter DL, Golomb MR. West Nile poliomyelitis in a 7-year-old child. Pediatr Neurol 2008;39:350-4
  • Vidwan G, Bryant KK, Puri V, et al. West Nile virus encephalitis in a child with left-side weakness. Clin Infect Dis 2003;37:e91-4
  • Yim R, Posfay-Barbe KM, Nolt D, et al. Spectrum of clinical manifestations of West Nile virus infection in children. Pediatrics 2004;114:1673-5
  • Braun LE, Tsuchida T, Spiegel H. Meningoencephalitis in a child complicated by myocarditis, quadriparesis and respiratory failure. Pediatr Infect Dis J 2006;25:853, 855-6
  • Natarajan N, Varman M. West Nile virus cerebellitis in a healthy 10-year-old child. Pediatr Infect Dis J 2007;26:767
  • Thabet FI, Servinsky SE, Naz F, et al. Unusual case of West Nile Virus flaccid paralysis in a 10-year-old child. Pediatr Neurol 2013;48:393-6
  • Heresi GP, Mancias P, Mazur LJ, et al. Poliomyelitis-like syndrome in a child with West Nile virus infection. Pediatr Infect Dis J 2004;23:788-9
  • DeBiasi RL, Parsons JA, Grabert BE. West Nile virus meningoencephalitis in an immunocompetent adolescent. Pediatr Neurol 2005;33:217-19
  • Barzon L, Pacenti M, Ulbert S, Palù G. Latest developments and challenges in the diagnosis of human West Nile virus infection. Expert Rev Anti Infect Ther 2015;13:327-42
  • Prince HE, Tobler LH, Lapé-Nixon M, et al. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 2005;43:4316-20
  • Papa A, Danis K, Athanasiadou A, et al. Persistence of West Nile virus immunoglobulin M antibodies. Greece. J Med Virol 2011;83:1857-60
  • Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008;198:984-93
  • Barzon L, Pacenti M, Franchin E, et al. Excretion of West Nile virus in urine during acute infection. J Infect Dis 2013;208:1086-92
  • Barzon L, Pacenti M, Franchin E, et al. Isolation of West Nile virus from urine samples of patients with acute infection. J Clin Microbiol 2014;52:3411-13
  • Available from: www.cdc.gov/westnile/healthcareproviders/healthcareproviders-treatmentprevention.html
  • Soldatou A, Vartzelis G, Vorre S, et al. A toddler with acute flaccid paralysis due to West Nile virus infection. Pediatr Infect Dis J 2013;32:1023-4
  • Thabet FI, Servinsky SE, Naz F, et al. Unusual case of West Nile Virus flaccid paralysis in a 10-year-old child. Pediatr Neurol 2013;48:393-6
  • Nathan DB, Samina I, Orr N. High titer human immunoglobulin as a specific therapy against West Nile virus encephalitis. Hum Vaccin 2010;6
  • Morelli MC, Sambri V, Grazi GL, et al. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. Clin Infect Dis 2010;51:e34-7
  • Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 2003;188:1-4
  • Hart JJr, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis 2014;14:248
  • Lewis M, Amsden JR. Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course. Pharmacotherapy 2007;27:455-8
  • Chan-Tack KM, Forrest G. Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis. Scand J Infect Dis 2005;37:944-6
  • Bellini R, Zeller H, Van Bortel W. A review of the vector management methods to prevent and control outbreaks of West Nile virus infection and the challenge for Europe. Parasit Vectors 2014;7:323
  • Centers for Disease Control and Prevention. Division of Vector-Borne Diseases. West Nile virus in the United States: Guidelines for surveillance, prevention, and control. 4th Revision. 2013
  • Chabierski S, Barzon L, Papa A, et al. Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop. BMC Infect Dis 2014;14:246
  • Diamond MS. Progress on the development of therapeutics against West Nile virus. Antiviral Res 2009;83:214-27
  • Bollati M, Alvarez K, Assenberg R, et al. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res 2010;87:125-48
  • Lazear HM, Diamond MS. New insights into innate immune restriction of West Nile virus infection. Curr Opin Virol 2015;11:1-6
  • Luo D, Vasudevan SG, Lescar J. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Antiviral Res 2015;118:148-58
  • Ulbert S, Magnusson SE. Technologies for the development of West Nile virus vaccines. Future Microbiol 2014;9:1221-32
  • Ishikawa T, Yamanaka A, Konishi E. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine 2014;32:1326-37
  • Zohrabian A, Hayes EB, Petersen LR. Cost-effectiveness of West Nile virus vaccination. Emerg Infect Dis 2006;12:375-80
  • Trevisan M, Sinigaglia A, Desole G, et al. Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems. Viruses 2015;7:3835-56
  • Graham JB, Thomas S, Swarts J, et al. Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes. MBio 2015;6:e00493-15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.